Внесок користувача
(найновіші • найдавніші) Переглянути (новіших 50 • старіших 50) (20 • 50 • 100 • 250 • 500).
- 12:20, 20 серпня 2018 (різн. • історія) . . (+6217) . . Н For the advancement of methylated and unmethylated LCR HPV16 subjected to in vitro methylation with the SssI CpGmethylase (For the advancement of methylated and unmethylated LCR HPV16 subjected to in vitro methylation with the SssI CpGmethylase) (поточна)
- 07:32, 21 червня 2018 (різн. • історія) . . (+4829) . . Н The autophagy adaptor molecule p62 is included clearance to mitochondria only after their depolarization (The autophagy adaptor molecule p62 is included clearance to mitochondria only after their depolarization) (поточна)
- 08:51, 25 травня 2018 (різн. • історія) . . (+4480) . . Н An analogous modify is noticed in migrating fibroblastswhere big central adhesions are likely to disperse when MII activity is inhibited (An analogous modify is noticed in migrating fibroblastswhere big central adhesions are likely to disperse when MII activity is inhibited) (поточна)
- 06:33, 12 квітня 2018 (різн. • історія) . . (+4107) . . Н The fundamental set off for mitotic cell loss of life for the duration of prolonged mitotic arrest is at the moment unclear (The fundamental set off for mitotic cell loss of life for the duration of prolonged mitotic arrest is at the moment unclear) (поточна)
- 09:04, 2 квітня 2018 (різн. • історія) . . (+4162) . . Н Nevertheless no mutants carrying substitutions in far more than 1 subunit at the same time have been received (Створена сторінка: Furthermore, recombinant human activated protein C exhibiting anti-inflammatory and anticoagulant activities has shown efficiency in sepsis remedy. A variety of...) (поточна)
- 09:06, 30 березня 2018 (різн. • історія) . . (+4162) . . Н Pursuing this process strains not able to expand consistently had been determined as false positives (Pursuing this process strains not able to expand consistently had been determined as false positives) (поточна)
- 11:04, 29 березня 2018 (різн. • історія) . . (+4235) . . Н Following this process strains not able to develop consistently ended up identified as untrue positives (Створена сторінка: The produced ligand [http://www.abmole.com/products/azd6244.html AZD6244 MEK inhibitor] conformations were energy minimized with CHARMm pressure field and a gra...) (поточна)
- 08:56, 22 березня 2018 (різн. • історія) . . (+4235) . . Н It is intriguing to emphasize that compounds showed an outstanding correlation amongst enzyme inhibition (Створена сторінка: Furthermore, in order to refine the fragments of PL2 and Hhip L2 and also to notice the [http://www.abmole.com/products/alk5-inhibitor-ii.html ALK5 Inhibitor II...) (поточна)
- 13:05, 21 березня 2018 (різн. • історія) . . (+4048) . . Н Ultimately it need to be mentioned that other system different kind launch could guide to gradual and nearly irreversible (Створена сторінка: To receive a complex framework of the Shh with robotnikinin prior to MD simulation, docking simulations and consensus scoring calculations had been conducted. T...) (поточна)
- 11:39, 19 березня 2018 (різн. • історія) . . (+4026) . . Н For occasion compounds cis isomers exhibited reduced action the corresponding trans isomers ended up inactive (Створена сторінка: These results are consistent with the earlier reports showing that DM-relevant conditions induce amyloidogenesis and Aβ pathology in rodent designs. Though a...) (поточна)
- 11:23, 19 березня 2018 (різн. • історія) . . (+4210) . . Н The corresponding trans isomer is inactive increasing the heterocycle reactivity or could be alone a pharmacophore (Створена сторінка: Although some preliminary studies experienced suggested the existence of pathogenic autoantibodies against distinct pancreatic antigens, there is minor evidence...) (поточна)
- 07:48, 12 березня 2018 (різн. • історія) . . (+4054) . . Н To counter the drug resistance dilemma there is a critical need to recognize new drug targets (Створена сторінка: These conclusions are regular with the earlier scientific studies exhibiting that DM-associated problems induce amyloidogenesis and Aβ pathology in rodent ve...) (поточна)
- 08:34, 9 березня 2018 (різн. • історія) . . (+4095) . . Н To counter the drug resistance problem there is a critical require to determine new drug targets (Створена сторінка: These results are consistent with the preceding reports displaying that DM-relevant problems induce amyloidogenesis and Aβ pathology in rodent models. Despit...) (поточна)
- 13:17, 7 березня 2018 (різн. • історія) . . (+4185) . . Н In addition multidrug resistant and extensively drug resistant strains continue to evolve creating existing treatment options ineffective (Створена сторінка: Cardiac Fe excess in hemochromatosis causes fibrosis without having swelling. Attachment of monocytes to, and penetration of, cardiomyocyte plasma membranes and...) (поточна)
- 13:05, 7 березня 2018 (різн. • історія) . . (+4161) . . Н At a subset of genes but deacetylation right after extended publicity was a more standard response (Створена сторінка: Although some preliminary reports experienced suggested the presence of pathogenic autoantibodies from specific pancreatic antigens, there is small evidence to...) (поточна)
- 08:37, 5 березня 2018 (різн. • історія) . . (+5041) . . Н Importantly the current research also investigated the effects of everolimus on residual ailment soon after intralesional curettage (Створена сторінка: In instances exactly where a genome is available as a research design, identification rates for big-scale proteomic analyses are normally 35-60%, indicating the...) (поточна)
- 08:49, 2 березня 2018 (різн. • історія) . . (+4904) . . Н Whether everolimus would be in a position to demonstrate the very same antitumor exercise in all chondrosarcoma subtypes will be tested (Створена сторінка: It is noteworthy that our prior EMF scientific studies recognized the initial biologic mechanisms that could explain the EMF-induced cognitive positive aspects,...) (поточна)
- 08:39, 2 березня 2018 (різн. • історія) . . (+6206) . . Н This suggests that everolimus could be worth checking out as adjuvant treatment at minimum in sufferers with quality greater chondrosarcoma (Створена сторінка: In addition, presently accessible medicines antagonists) only deal with/mask Ad signs for about one particular yr, if at all - none of them straight slow or red...) (поточна)
- 09:03, 1 березня 2018 (різн. • історія) . . (+5016) . . Н Whether everolimus would be capable to show the identical antitumor action in all chondrosarcoma subtypes will be examined (Створена сторінка: It is noteworthy that our prior EMF studies identified the 1st biologic mechanisms that could clarify the EMF-induced cognitive benefits, which we also describe...) (поточна)
- 11:00, 28 лютого 2018 (різн. • історія) . . (+4982) . . Н Due to the fact of their extracellular matrix lower proportion of dividing cells and bad vascularity chondrogenic tumors are relatively (Створена сторінка: It is noteworthy that our prior EMF studies identified the initial biologic mechanisms that could make clear the EMF-induced cognitive advantages, which we also...) (поточна)
- 06:20, 27 лютого 2018 (різн. • історія) . . (+6263) . . Н Scientific administration of these next most common kind of skeletal malignancies right after osteosarcoma has remained mainly unchanged (Створена сторінка: Moreover, at the moment obtainable drugs antagonists) only take care of/mask Advert symptoms for about one calendar year, if at all - none of them right sluggis...) (поточна)
- 06:32, 26 лютого 2018 (різн. • історія) . . (+4959) . . Н Simply because of their extracellular matrix minimal percentage of dividing cells and bad vascularity chondrogenic tumors are fairly (Створена сторінка: It is noteworthy that our prior EMF scientific studies recognized the very first biologic mechanisms that could clarify the EMF-induced cognitive advantages, wh...) (поточна)
- 06:24, 26 лютого 2018 (різн. • історія) . . (+6185) . . Н Scientific administration of these next most common sort of skeletal malignancies soon after osteosarcoma has remained mainly unchanged (Створена сторінка: Additionally, at the moment available medicines antagonists) only treat/mask Advert symptoms for about a single calendar year, if at all - none of them directly...) (поточна)
- 09:29, 23 лютого 2018 (різн. • історія) . . (+6208) . . Н Clinical management of these second most common sort of skeletal malignancies right after osteosarcoma has remained mainly unchanged (Створена сторінка: In addition, presently available medicines antagonists) only deal with/mask Ad signs for about a single yr, if at all - none of them straight slow or reduce [ht...) (поточна)
- 05:22, 14 лютого 2018 (різн. • історія) . . (-8) . . м Catalyses the reversible transfer of two carbons from a ketose donor substrate to an aldose acceptor substrate (поточна)
- 06:36, 12 лютого 2018 (різн. • історія) . . (+5321) . . Н In resolution values in contaminated cells to provide as a foundation for the advancement of possible new antiviral medicines (Створена сторінка: The culture stage is timed sort the cellsâ first exposure to virus. All three incubations are at 37 uC. All sera are heat inactivated at fifty six uC for o...) (поточна)
- 05:40, 9 лютого 2018 (різн. • історія) . . (+5428) . . Н Catalyses the reversible transfer of two carbons from a ketose donor substrate to an aldose acceptor substrate (Створена сторінка: The ratio information are also presented as linear regression plots in figure five. Plots of virus dose towards numbers of fluorescent cells had been analyzed b...)
- 05:22, 8 лютого 2018 (різн. • історія) . . (+5043) . . Н Therefore Necdin expression in LMPs might attenuate the reaction when p53 activity is needed (Створена сторінка: Quantitative reverse transcription actual-time PCR was utilized to quantify the amounts of mRNA in the ears or lymph nodes using custom RT2 Profiler PCR Arrays...) (поточна)
- 08:27, 7 лютого 2018 (різн. • історія) . . (+5150) . . Н Therefore Necdin expression in LMPs may attenuate the reaction when p53 activity is required (Створена сторінка: Quantitative reverse transcription true-time PCR was employed to quantify the amounts of mRNA in the ears or lymph nodes making use of custom RT2 Profiler PCR A...) (поточна)
- 10:01, 5 лютого 2018 (різн. • історія) . . (+4704) . . Н Whether the rising population came from a selective force for cells ready to tolerate large Necdin expression (Створена сторінка: Despite the fact that many scientific studies have aimed at resolving the position of thylakoidsâ fatty acid saturation in inducing thermotolerance to phot...) (поточна)
- 09:52, 5 лютого 2018 (різн. • історія) . . (+4915) . . Н Even though prolonged-expression Necdin overexpression was not incompatible with cell expansion we can't yet conclude (Створена сторінка: Importantly, the doses of Sal A utilized in dogs ended up extremely high as compared to clinical apply and to rats the 17, 50, and a hundred and fifty mg/ kg/wo...) (поточна)
- 09:34, 31 січня 2018 (різн. • історія) . . (+4687) . . Н Whether the rising population came from a selective strain for cells in a position to tolerate higher Necdin expression (Створена сторінка: Despite the fact that a lot of scientific studies have aimed at resolving the position of thylakoidsâ fatty acid saturation in inducing thermotolerance to...) (поточна)
- 09:14, 30 січня 2018 (різн. • історія) . . (+4735) . . Н Necdin interacts with p53 and possibly modulates its action which raises the likelihood that PyLT exerts (Necdin interacts with p53 and possibly modulates its action which raises the likelihood that PyLT exerts) (поточна)
- 08:23, 29 січня 2018 (різн. • історія) . . (+4880) . . Н Necdin interacts with p53 and perhaps modulates its exercise which raises the possibility that PyLT exerts (Створена сторінка: As a result, soon after six h of exposure, the DKS and AC taken care of,twenty and 34% of their original exercise, respectively. However, upon including lincomy...) (поточна)
- 07:40, 25 січня 2018 (різн. • історія) . . (+4808) . . Н We identified Necdin among a set of genes that have been regularly upregulated following PyLT expression in NIH3T3 cells (Створена сторінка: As a result, following 6 h of exposure, the DKS and AC taken care of,twenty and 34% of their initial action, respectively. However, upon introducing lincomycin...) (поточна)
- 07:47, 24 січня 2018 (різн. • історія) . . (+4866) . . Н Based mostly on this evidence we hypothesized that in addition to its immortalizing action modulates important functions in early (Створена сторінка: Importantly, the doses of Sal A employed in puppies ended up very large as when compared to medical apply and to rats the seventeen, 50, and 150 mg/ kg/working...) (поточна)
- 12:11, 23 січня 2018 (різн. • історія) . . (+5381) . . Н We discovered Necdin among a established of genes that were consistently upregulated following PyLT expression in NIH3T3 cells (Створена сторінка: Even so, endothelial cell development and proliferation was comparatively unaffected in this context. Thus, our results are of value not only for demonstrating...) (поточна)
- 12:01, 23 січня 2018 (різн. • історія) . . (+5190) . . Н Primarily based on this proof we hypothesized that in addition to its immortalizing exercise modulates important features in early (Створена сторінка: The cationic peptide may bind to the anionic buildings of the malignant mobile membrane in a carpetlike method. Following achieving a threshold concentration th...) (поточна)
- 11:16, 19 січня 2018 (різн. • історія) . . (+5121) . . Н A similar finding was documented among aryl rings is vital for aggregation activity when they when compared (Створена сторінка: The cationic peptide could bind to the anionic constructions of the malignant cell membrane in a carpetlike way. Following reaching a threshold focus the peptid...) (поточна)
- 08:40, 12 січня 2018 (різн. • історія) . . (+5399) . . Н Dose-dependently XG-102 considerably diminished the clinical parameters ulceration crypt deformations immune cell infiltration (Створена сторінка: Even so, endothelial mobile advancement and proliferation was relatively unaffected in this context. Hence, our conclusions are of relevance not only for demons...) (поточна)
- 08:23, 10 січня 2018 (різн. • історія) . . (+4943) . . Н Results reveal that the JNK inhibitor guards in opposition to characteristic pathological characteristics of TNBS-triggered colon swelling (Створена сторінка: The intention of our study is to 1st look into the conversation of fulllength bestrophin-1 with b-subunits and next, the affect of bestrophin-1 on the potential...) (поточна)
- 08:24, 9 січня 2018 (різн. • історія) . . (+5032) . . Н Systemic C75 remedy fails to elicit equivalent activation sample in spite of the truth lead to raises in rest (Створена сторінка: The purpose of our research is to 1st examine the conversation of fulllength bestrophin-1 with b-subunits and next, the influence of bestrophin-1 on the capabil...) (поточна)
- 09:40, 8 січня 2018 (різн. • історія) . . (+6020) . . Н In our examine however C75 induced dosedependent and long-long lasting suppression of REMS cholecystokinin (Створена сторінка: In addition, for a single of the aspects involved in the Epicardial lock, Wif1, we present with model systems for the 1st and 2nd coronary heart fields that it...) (поточна)
- 09:49, 5 січня 2018 (різн. • історія) . . (+6013) . . Н In our research however C75 induced dosedependent and prolonged-lasting suppression of REMS cholecystokinin (Створена сторінка: In addition, for one of the factors associated in the Epicardial lock, Wif1, we display with model programs for the first and 2nd heart fields that it enhances...) (поточна)
- 10:26, 4 січня 2018 (різн. • історія) . . (+5998) . . Н Experiment was an in vivo experiment which assessed regardless of whether cilostazol impacted the fertility of mice (Створена сторінка: In addition, for 1 of the elements involved in the Epicardial lock, Wif1, we present with design systems for the initial and 2nd heart fields that it enhances c...) (поточна)
- 08:58, 3 січня 2018 (різн. • історія) . . (+6195) . . Н The developmental likely of the resulting embryos fertilized by the ICSI approach in the early phase of development (Створена сторінка: To even more substantiate these observations Wif1 expression was knocked down using gene-distinct siRNA. Wif1 knockdown was verified at 2 days following transfe...) (поточна)
- 08:47, 29 грудня 2017 (різн. • історія) . . (+6193) . . Н Even so enzastaurin has also been reported to have tiny result on Akt phosphorylation in glioma cells (Створена сторінка: To more substantiate these observations Wif1 expression was knocked down using gene-particular siRNA. Wif1 knockdown was verified at 2 times after transfection....) (поточна)
- 08:36, 29 грудня 2017 (різн. • історія) . . (+4970) . . Н In a number of most cancers kinds whilst Akt phosphorylation has been reported to be downregulated by enzastaurin likely (Створена сторінка: The goal of our research is to first examine the interaction of fulllength bestrophin-1 with b-subunits and secondly, the affect of bestrophin-1 on the capabili...) (поточна)
- 08:23, 28 грудня 2017 (різн. • історія) . . (+4880) . . Н Erk1/2 activation is commonly found in independent of mutational status and are critical for growth (Створена сторінка: Plasma was eliminated and stored at 280uC. For the breast cancer mouse design, transgenic FVB/NTg 634Mul/J mice had been obtained from the Nationwide Most cance...) (поточна)
- 09:24, 27 грудня 2017 (різн. • історія) . . (+4969) . . Н It is effectively documented that level mutations in loop areas have resulted in quick sulfa drug resistance (Створена сторінка: The intention of our examine is to initial look into the interaction of fulllength bestrophin-1 with b-subunits and next, the impact of bestrophin-1 on the capa...) (поточна)
(найновіші • найдавніші) Переглянути (новіших 50 • старіших 50) (20 • 50 • 100 • 250 • 500).